Pharmaceutical and Biotechnology EvaluatePharma forecast that R&D spending by pharmaceutical companies will rise 1.0% this year to $134 billion, according to a June 2011 report. From now until 2016, R&D spending by drug companies is expected to grow an average of 2.5% annually to total $147 billion. EvaluatePharma forecasted prescription drug revenues to have a […]
The lab equipment market, as defined by IBO, consists of eight categories of techniques. The overall market totaled nearly $2.5 billion in 2011. With a 2012 growth rate of more than 4%, the market is expected to increase by $100 million by the end of 2012. While laboratory equipment of various types is found in […]
The general analytical techniques (GAT) section of the analytical instrument market is a collection of vary basic laboratory instruments: electrochemistry systems, laboratory balances, radioactivity instruments, dissolution testing equipment, and continuous flow and discrete analyzers. Although these technologies are fundamentally different from each other, they share similar market characteristics. These instruments are primarily low-end technologies, with […]
Total market demand for materials characterization instruments reached $2.18 billion in 2011 and is forecast to be $2.29 billion in 2012, representing growth of 5.2%. These instruments characterize the physical properties of a wide variety of materials. The different technology segments are organized by the specific kind of measurements being made or the specific sample […]
Surface science encompasses a number of technology platforms that can broadly be termed microscopes; they provide imaging and analysis of microscopic features of samples. Market demand reached $5 billion in 2011, and sales growth for the coming year is forecast at 6.7% for the surface science sector. The largest individual technology segment is optical microscopy, […]
A hearing held late last month by the US House of Representatives’ Committee on Science, Space and Technology presented new details on the status of American Recovery and Reinvestment Act (ARRA) research funding. The table below, based on hearing documents, provides an update. ARRA Science and Technology Funding as of November 15, 2011 Total Available […]
This year proved to be difficult for lab product– and instrument-related IPOs (see table). The year’s largest debut was Fluidigm (see IBO 2/15/11). Jiangsu Skyray Instruments listed on the Shenzhen Stock Exchange’s ChiNext Market (see IBO 1/31/11), Microsaic Systems listed on the London Stock Exchange’s AIM Market (see IBO 4/15/11), and Norton Scientific debuted in […]
PCR has been around for more than 25 years. As bench space becomes more scarce, the demand for more miniaturized PCR systems has grown. Handheld and portable PCR systems, which were introduced to the market in the early 2000s, add a variety of applications not possible with benchtop PCR systems. In vitro diagnostics and point-of-care […]
Due to the IBO January 15, 2012, forecast issue, a condensed version of the third-quarter IBO Lab Equipment/Consumables Index is presented in this issue. Third-quarter revenues for the Index grew 6.4%, 4.2% organically, to $3,834.8 million. Operating profits rose 4.9% to $707.2 million. Adjusted operating margin improved 50 basis points to 17.7% of sales. Kewaunee […]
Surface zeta potential measurement used to require its own instrument. Now, Malvern Instruments has introduced the Surface Zeta Potential (SZP) cell, an accessory for Malvern’s Zetasizer Nano systems (the Nano Z, Nano ZS or Nano ZS90), which characterize nanoparticles and colloids. The cell allows the measurement of a sample in liquid. The cell began shipping […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
